CERTAIN CONTOURED MARGIN CERAMIC ABUTMENT

K073345 · Biomet 3i, Inc. · NHA · Mar 7, 2008 · Dental

Device Facts

Record IDK073345
Device NameCERTAIN CONTOURED MARGIN CERAMIC ABUTMENT
ApplicantBiomet 3i, Inc.
Product CodeNHA · Dental
Decision DateMar 7, 2008
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.3630
Device ClassClass 2
AttributesTherapeutic

Intended Use

BIOMET 3i Certain® Contoured Margin Ceramic Abutments are intended for use as an accessory to endosseous dental implants to support a prosthetic device in a partially or edentulous patient. The Certain® Contoured Margin Ceramic Abutments are intended for use to support single and multiple tooth prostheses, in the mandible or maxilla. The prosthesis is cement retained to the abutment.

Device Story

Device is a dental abutment used as an accessory to endosseous dental implants; supports single or multiple tooth prostheses in mandible or maxilla. Prosthesis is cement-retained to the abutment. Used by dental professionals in a clinical setting to restore patient dentition.

Clinical Evidence

No clinical data provided; substantial equivalence based on design and technological characteristics.

Technological Characteristics

Ceramic abutment with titanium insert and abutment screw; features internal connections for endosseous dental implants.

Indications for Use

Indicated for partially or edentulous patients requiring single or multiple tooth prostheses supported by endosseous dental implants in the mandible or maxilla.

Regulatory Classification

Identification

An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.

Special Controls

*Classification.* Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Ko 73345 # ROMET 31 MAR - 7 2008 #### 510(k) SUMMARY #### BIOMET 3i Contoured Margin Ceramic Abutment BIOMET 3i, Inc. Priscilla Caro BIOMET 3i, Inc. Riverside Dr Tel. 561-776-6785 Fax 561-514-6316 bmitter: 4555 Riverside Dr Palm Beach Gardens, FL 33410 Regulatory Affairs Specialist Palm Beach Gardens, FL 33410 ntact Person: ate Prepared: ame of Device rade/Proprietary Name: ommon/Usual Name Slassification Name assification November 27, 2007 Certain® Contoured Margin Ceramic Abutment Not available Abutment, implant, dental, endosseous Class II 21CFR 872.3630 oduct Code edicate Devices NHA BIOMET 3i Dental Ceramic Abutment Zimmer® Contour Ceramic Abutment tended Use / Indications for Use BIOMET 31 Certain® Contoured Margin Ceramic Abutments are intended for use as an cessory to endosseous dental implants to support a prosthetic device in a partially or contains patient. The Certain® Contoured Margin Ceramic Abutments are intended for use support single and multiple tooth prostheses, in the mandible or maxilla. The prosthesis is ment retained to the abutment. {1}------------------------------------------------ ## echnological Characteristics The BIOMET 3i Certain® Contoured Margin Ceramic Abutment design consists of The BIOME I 37 Certains Contoured in buttent screw. These devices worldwords ffferent abutments \$125, thanimi insort and all about - 11.00 as 1000 as 1000 and and propriate reatures and 311 with internal connections. ## ubstantial Equivalence The BIOMET 3i Certain® Contoured Margin Ceramic Abutments substantially equivalent o the BIOMET 37 Certain® Contouroum Margin Corants and Zimmer® Contour Ceramic of the predicate DrOWLY 37 Denat Condid uses, indications, technological characteristics, Abuttlent having the same general internets assoss, increased on the minor technological differences wetween the proposed devices components and their predicate devices raise no new issues of afety or effectiveness. {2}------------------------------------------------ Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 ## MAR - 7 2008 Ms. Priscilla Caro Regulatory Affairs Specialist Biomet 3i, Incorporated 4555 Riverside Drive Palm Beach Gardens, Florida 33410 Re: K073345 Trade/Device Name: Certain® Contoured Margin Ceramic Abutment Regulation Number: 21 CFR 872,3630 Regulation Name: Endosseous Dental Implant Abutment Regulatory Class: II Product Code: NHA Dated: February 29, 2008 Received: March 3, 2008 Dear Ms. Caro: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Page 2 - Ms. Caro Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Sylvie Y. Mohano md. Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ # BOMET 31 ## cations for Use Number (if known): novice Name: Certain® Contoured Margin Ceramic Abutment Hons for Use: on BE 3i Certain® Contoured Margin Ceramic Abutments are intended for use as an to endosseous dental implants to support a prosthetic device in a partially or continus patient. The Certain® Contoured Margin Ceramic Abutments are intended for use to more single and multiple tooth prostheses, in the mandible or maxilla. The prosthesis is and retained to the abutment. ### INFY WHETHER THE DEVICE IS INTENDED FOR PRESCRIPTION USE DOR OVER-THE-COUNTER USE.] cription Use & 1 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) ### ISE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Susan Rumore (Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices 510(k) Number: K672245 Page of
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%